Literature DB >> 8714693

Determination versus differentiation and the MyoD family of transcription factors.

L A Megeney1, M A Rudnicki.   

Abstract

The myogenic regulatory factors (MRFs) form a family of basic helix-loop-helix transcription factors consisting of Myf-5, MyoD, myogenin, and MRF4. The MRFs play key regulatory roles in the development of skeletal muscle during embryogenesis. Sequence homology, expression patterns, and gene-targeting experiments have revealed a two-tiered subclassification within the MRF family. Myf-5 and MyoD are more homologous to one another than to the others, are expressed in myoblasts before differentiation, and are required for the determination or survival of muscle progenitor cells. By contrast, myogenin and MRF4 are more homologous to one another than to the others and are expressed upon differentiation, and myogenin is required in vivo as a differentiation factor while the role of MRF4 remains unclear. On this basis, MyoD and Myf-5 are classified as primary MRFs, as they are required for the determination of myoblasts, and myogenin and MRF4 are classified as secondary MRFs, as they likely function during terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8714693     DOI: 10.1139/o95-080

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  62 in total

1.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD.

Authors:  Z Yablonka-Reuveni; M A Rudnicki; A J Rivera; M Primig; J E Anderson; P Natanson
Journal:  Dev Biol       Date:  1999-06-15       Impact factor: 3.582

3.  Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat.

Authors:  David Peters; Ilona A Barash; Michael Burdi; Philip S Yuan; Liby Mathew; Jan Fridén; Richard L Lieber
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

4.  Transcriptional profile of GTP-mediated differentiation of C2C12 skeletal muscle cells.

Authors:  Rosa Mancinelli; Tiziana Pietrangelo; Geoffrey Burnstock; Giorgio Fanò; Stefania Fulle
Journal:  Purinergic Signal       Date:  2011-12-01       Impact factor: 3.765

5.  In vitro evaluation of human muscle satellite cell migration prior to fusion into myotubes.

Authors:  B Chazaud; C Christov; R K Gherardi; G Barlovatz-Meimon
Journal:  J Muscle Res Cell Motil       Date:  1998-11       Impact factor: 2.698

6.  A two-hybrid system for transactivator bait proteins.

Authors:  M Hirst; C Ho; L Sabourin; M Rudnicki; L Penn; I Sadowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

7.  The expression of nestin delineates skeletal muscle differentiation in the developing rat esophagus.

Authors:  Peng-Han Su; Tung-Cheng Wang; Zong-Ruei Wong; Bu-Miin Huang; Hsi-Yuan Yang
Journal:  J Anat       Date:  2011-03       Impact factor: 2.610

8.  Influence of PDGF-BB on proliferation and transition through the MyoD-myogenin-MEF2A expression program during myogenesis in mouse C2 myoblasts.

Authors:  Z Yablonka-Reuveni; A J Rivera
Journal:  Growth Factors       Date:  1997       Impact factor: 2.511

9.  Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans.

Authors:  P Hespel; B Op't Eijnde; M Van Leemputte; B Ursø; P L Greenhaff; V Labarque; S Dymarkowski; P Van Hecke; E A Richter
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Caspase 3 activity is required for skeletal muscle differentiation.

Authors:  Pasan Fernando; John F Kelly; Kim Balazsi; Ruth S Slack; Lynn A Megeney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.